<DOC>
	<DOCNO>NCT02308670</DOCNO>
	<brief_summary>The primary aim study observe change MRI MS patient switch 20mg injections/day 3 40mg injections/week glatiramer acetate .</brief_summary>
	<brief_title>Evaluate Effect Switching From Daily Injections 20mg Glatiramer Acetate ( GA ) 40mg GA Three Times Week Subjects With Relapsing-remitting Multiple Sclerosis</brief_title>
	<detailed_description>The primary aim study observe effect switch daily injection 20mg glatiramer acetate ( GA ) ( 20mg/daily ) GA 40mg three time week ( 40mg x 3/weekly ) thalamus pathology , measure change diffusion-tensor imaging ( DTI ) patient relapsing-remitting multiple sclerosis ( RRMS ) . We hypothesize GA 40mg x 3/weekly exert similar , well effect prevention thalamic pathology , compare GA 20mg/daily . The secondary objective study investigate effect switch GA 20mg/daily GA 40mg x 3/weekly evolution microstructural change normal appear white matter ( NAWM ) normal appear gray matter ( NAGM ) , measure DTI .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>MS patient diagnose MS accord McDonald criterion MS patient relapse disease course Being GA monotherapy ( 20mg/daily sc ) least 12 month prior standard care MRI time switch GA 40mg x 3/weekly Having standard care 3T MRI scan GA 20mg/daily treatment least 1218 month prior start day GA 40mg x 3/weekly time switch GA 40mg x 3/weekly Age 18 Pass MRI health screening ( case EGFR &lt; 59 , contrast apply ) None exclusion criterion Patients relapse within 30 day prior MRI scan date Patients receive steroid treatment within 30 day prior MRI scan date Women pregnant , lactate childbearing age consent approve contraceptive use study MS patient use imunomodulatory immunosuppressant treatment GA 12 month prior start GA 40mg 3/weekly ( e.g. , IFNÎ² , mitoxantrone , cyclophosphamide , cladribine , fludarabine , cyclosporine , total body , azathioprine , methotrexate , IVIG , cellcept , natalizumab , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>